Rex Health Ventures Hero Image
STRATEGIC INVESTMENT.
BREAKTHROUGH INNOVATION.

Rex Health Ventures enables groundbreaking work to advance the future of health

Rex Health Ventures Building

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health.

  • Entrepreneur-friendly strategic investor that speeds access to new healthcare products and services to improve patient care
  • Established by UNC REX Healthcare in 2012 as part of its commitment to innovation, Rex Health Ventures currently operates as the early-stage investment fund for all of UNC Health System
  • Partners with emerging companies throughout North Carolina and the U.S.
  • Leverages the talent and subject matter experts across the UNC REX and UNC Health Care network

Portfolio Spotlight: Phononic

Phononic is revolutionizing cooling and heating with solid-state thermal management solutions. Named to CNBC’s 2016 Disruptor 50 list for its innovation within the cooling and heating industry, as well as CNBC’s Disruptor 50 list for both 2016 and 2017, Phononic provides solid-state semiconductor technology that can be applied to everything from refrigeration to fiber optics, removing the barriers of traditional approaches and ushering in a new era of cooling and heating.

UNC REX served as the first testing site for Phononic’s medical grade refrigerator, which will now be installed throughout the new NC Heart and Vascular hospital. Learn more in this video.

Meet the Rex Health Ventures Team

Anita Watkins

Managing Director

John Perez Rex Health Ventures Healthcare Venture Capital

John Perez

Managing Director

Evan Bernath

Investment Associate

Get the latest investment news from Rex Health Ventures:

Carta Healthcare Secures $18.25 Million in Series B1 Funding to Accelerate AI-Powered Clinical Data Abstraction and Analytics

SAN FRANCISCO, May 7, 2025 /PRNewswire/ — Carta Healthcare, a leading provider of AI-powered clinical data abstraction, today announced it has secured $18.25 million in Series B1 financing. This investment will accelerate the company’s growth as demand surges among health systems and life sciences organizations for AI-driven innovation that transforms clinical data into valuable insights. The investment was led by […]

410 Medical Secures $14 Million Series B Financing to Expand Access to Life-Saving Resuscitation Technologies

DURHAM, N.C., March 17, 2025 — 410 Medical, Inc., a medical device company focused on innovative technologies for emergency and critical care, today announced the completion of a $14 million Series B financing. Existing investor Hatteras Venture Partners led the funding round with participation from Orlando Health Ventures, Ballad Ventures, OSF Healthcare, WakeMed, Rex Health Ventures, […]

Synaptrix scores $10m for postoperative pain relief device

Synaptrix, an Atlanta based medical device startup, announces Series A First-Close of $10M to develop NOVABLOC™, a first-in-kind drug-free solution for extended post-surgical pain relief and elimination of opioids. Proceeds will support a pivotal study, regulatory submission, and commercialization of the company’s proprietary NOVABLOC™ system. The team announced a $10 million Series A last week […]